Mechanistic description
Elevated MMP-9/TIMP-1 ratio reflects net proteolytic activity against the BBB, causing degradation of tight junction proteins (claudin-5, occludin, ZO-1) and increased permeability. This imbalance precedes measurable cognitive decline and represents a blood-accessible biomarker. The hypothesis has the strongest evidence base with the additional advantage of having clinically plausible interventions available for repurposing (anti-MMP-9 antibodies such as anrukinzumab and GS-5745). Primary limitation is the lack of specificity for neurodegeneration versus systemic inflammation.
Evidence for (8)
Tissue inhibitor metalloproteinase-1 and clinical outcomes after acute ischemic stroke.
Serum matrix metallopeptidase-9 levels in infantile epileptic spasms syndrome of unknown etiology.
An evaluation of matrix metalloproteinase-9 (Mmp-9) and tissue inhibitor metalloproteinase-1 (Timp-1) Serum levels and the Mmp-9/Timp-1 Ratio in Covid-19 patients.
May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?
Plasma MMP-9/TIMP-1 ratio serves as a novel potential biomarker in Alzheimer's disease.
Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio.
Comparison of MMP-2 and TIMP-2 expressions in yak testes at different ages.
Differential expression of MMP-2, MMP-9 and TIMP proteins in thoracic aortic aneurysm - comparison with and without bicuspid aortic valve: a meta-analysis.
Evidence against (3)
MMP-9 plays beneficial roles in CNS injury recovery
MMP-9 levels showed no independent association with dementia risk after cardiovascular adjustment
Evidence base primarily from stroke models not directly translatable to chronic neurodegeneration
Evidence matrix
Supporting
- Tissue inhibitor metalloproteinase-1 and clinical outcomes after acute ischemic stroke. PMID:31551260 · 2019 · Neurology
- Serum matrix metallopeptidase-9 levels in infantile epileptic spasms syndrome of unknown etiology. PMID:39342693 · 2024 · Epilepsy Res
- An evaluation of matrix metalloproteinase-9 (Mmp-9) and tissue inhibitor metalloproteinase-1 (Timp-1) Serum levels and the Mmp-9/Timp-1 Ratio in Covid-19 patients. PMID:37545954 · 2023 · Afr Health Sci
- May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer? PMID:27853937 · 2017 · Pathol Oncol Res
- Plasma MMP-9/TIMP-1 ratio serves as a novel potential biomarker in Alzheimer's disease. PMID:37695608 · 2023 · Neuroreport
- Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio. PMID:24727739 · 2014 · PLoS One
- Comparison of MMP-2 and TIMP-2 expressions in yak testes at different ages. PMID:36932642 · 2023 · Reprod Domest Anim
- Differential expression of MMP-2, MMP-9 and TIMP proteins in thoracic aortic aneurysm - comparison with and without bicuspid aortic valve: a meta-analysis. PMID:25339161 · 2014 · Vasa
Contradicting
- MMP-9 plays beneficial roles in CNS injury recovery PMID:21722948
- MMP-9 levels showed no independent association with dementia risk after cardiovascular adjustment PMID:unknown
- Evidence base primarily from stroke models not directly translatable to chronic neurodegeneration PMID:29154112
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Matrix Metalloproteinase-9 and TIMP-1 Ratio in Peripheral Blood as an Early Ind…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-SDA-2026-04-26-gap-debate-20260426-011448-7c85f5dc-01-matrix-metalloproteinase-9-and-timp-1-ratio-in-p-da6babffdb
@misc{scidex_hypothesis_hsda2026,
title = {Matrix Metalloproteinase-9 and TIMP-1 Ratio in Peripheral Blood as an Early Ind…},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-SDA-2026-04-26-gap-debate-20260426-011448-7c85f5dc-01-matrix-metalloproteinase-9-and-timp-1-ratio-in-p-da6babffdb},
note = {SciDEX artifact hypothesis:h-SDA-2026-04-26-gap-debate-20260426-011448-7c85f5dc-01-matrix-metalloproteinase-9-and-timp-1-ratio-in-p-da6babffdb}
}